Evidence map›Paper›PMID 31811121›Full record

ArticleNature communications2019

CSB promoter downregulation via histone H3 hypoacetylation is an early determinant of replicative senescence.

Clément Crochemore, Cristina Fernández-Molina, Benjamin Montagne, Audrey Salles, Miria Ricchetti

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Therapeutic targeting of senescent cells in the CNS.Nature reviews. Drug discovery · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Clément CrochemoreInstitut Pasteur, Stem Cells and Development, Department of Developmental and Stem Cell Biology, 75015, Paris, France.
Cristina Fernández-MolinaInstitut Pasteur, Stem Cells and Development, Department of Developmental and Stem Cell Biology, 75015, Paris, France.
Benjamin MontagneInstitut Pasteur, Stem Cells and Development, Department of Developmental and Stem Cell Biology, 75015, Paris, France.
Audrey SallesInstitut Pasteur, UTechS Photonic BioImaging PBI (Imagopole), Centre de Recherche et de Ressources Technologiques C2RT, Paris, France.
Miria RicchettiInstitut Pasteur, Stem Cells and Development, Department of Developmental and Stem Cell Biology, 75015, Paris, France. miria.ricchetti@pasteur.fr.ORCID http://orcid.org/0000-0002-7535-954X
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular senescence has causative links with ageing and age-related diseases, however, it remains unclear if progeroid factors cause senescence in normal cells. Here, we show that depletion of CSB, a protein mutated in progeroid Cockayne syndrome (CS), is the earliest known trigger of p21-dependent replicative senescence. CSB depletion promotes overexpression of the HTRA3 protease resulting in mitochondrial impairments, which are causally linked to CS pathological phenotypes. The CSB promoter is downregulated by histone H3 hypoacetylation during DNA damage-response. Mechanistically, CSB binds to the p21 promoter thereby downregulating its transcription and blocking replicative senescence in a p53-independent manner. This activity of CSB is independent of its role in the repair of UV-induced DNA damage. HTRA3 accumulation and senescence are partially rescued upon reduction of oxidative/nitrosative stress. These findings establish a CSB/p21 axis that acts as a barrier to replicative senescence, and link a progeroid factor with the process of regular ageing in human.

Indexed as

Cell LineCellular SenescenceCockayne SyndromeCyclin-Dependent Kinase Inhibitor p21DNADNA DamageDNA HelicasesDNA RepairDNA Repair EnzymesDown-RegulationEpigenomicsFibroblastsGene Expression RegulationGene Knockdown TechniquesHEK293 CellsHistonesCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DNADNA HelicasesDNA Repair EnzymesERCC6 protein, humanHistonesHTRA3 protein, humanPoly-ADP-Ribose Binding ProteinsSerine Endopeptidases

Identifiers

PMID31811121
PMCPMC6898346
OpenAlexW2994564296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.